Literature DB >> 33911149

Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey.

Marzieh Nikparvar1, Mohadeseh Khaladeh2, Hadi Yousefi3, Mohammadsadegh Vahidi Farashah4, Behzad Moayedi5, Masoumeh Kheirandish6.   

Abstract

Dyslipidemia, a major risk factor for cardiovascular diseases, has become a global issue. Due to the variations in the prevalence of dyslipidemia, this study aimed to evaluate dyslipidemia and its associated factors in women of the Bandare-Kong Cohort Study (BKNCD). This study was conducted on women from the population-based BKNCD, as part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Sociodemographic data, medical history, and anthropometric indices were collected. Dyslipidemia was defined as any lipid abnormality including low-density lipoprotein (LDL) ≥ 160, total cholesterol (TC) ≥ 240, high-density lipoprotein (HDL) < 40, or triglyceride > 200 mg/dl. From the 2223 women in this study (mean age: 48.28 ± 9.26 years), dyslipidemia was observed in 851 (38.3%). High TC was the most common lipid abnormality (18.5%) followed by high LDL (17.7%). Dyslipidemia was most prevalent among women aged 55-70 years, the married, those with < 6 years of education, the unemployed, the overweight or obese, with low socioeconomic status, diabetes, hypertension, and high waist circumference, those using the hookah and living in urban areas. Logistic regression revealed that women with high waist-to-hip ratio (WHR) (OR = 2.22, 95% CI 1.60-3.08), those aged 45-54 years (OR = 1.34, 95% CI 1.07-1.68) and 55-70 years (OR = 1.33, 95% CI 1.03-1.72), and those living in urban areas (OR = 1.35, 95% CI 1.05-1.73) were at significantly increased risk of dyslipidemia. In addition, the results were confirmed using deep neural network models. Dyslipidemia was highly prevalent in Iranian women in the southern coastal region. Central obesity, age over 45 years, and living in urban areas appear to be relatively significant risk factors for dyslipidemia among women.

Entities:  

Year:  2021        PMID: 33911149     DOI: 10.1038/s41598-021-88680-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  4 in total

1.  Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis.

Authors:  Xue Han; D Steven Fox; Michelle Chu; J Samantha Dougherty; Jeffrey McCombs
Journal:  J Manag Care Spec Pharm       Date:  2018-11

2.  Urbanization and non-communicable risk factors in the capital city of 6 big provinces of iran.

Authors:  Sh Yarahmadi; K Etemad; Ar Mahdavi Hazaveh; N Azhang
Journal:  Iran J Public Health       Date:  2013-01-01       Impact factor: 1.429

Review 3.  Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study.

Authors:  Ozra Tabatabaei-Malazy; Mostafa Qorbani; Tahereh Samavat; Farshad Sharifi; Bagher Larijani; Hossein Fakhrzadeh
Journal:  Int J Prev Med       Date:  2014-04

4.  Prevalence of Dyslipidemia in Urban and Rural Areas of the Northwest of Iran: The Sociodemographic, Dietary and Psychological Determinants.

Authors:  Jafar Sadegh Tabrizi; Leila Nikniaz; Homayoun Sadeghi-Bazargani; Mostafa Farahbakhsh; Zeinab Nikniaz; Mahdieh Abbasalizad Farhangi; Elham Eghbali
Journal:  Iran J Public Health       Date:  2019-05       Impact factor: 1.429

  4 in total
  4 in total

1.  Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study.

Authors:  Zahra Jamali; Mojgan Noroozi Karimabad; Parvin Khalili; Tabandeh Sadeghi; Ahmadreza Sayadi; Faegheh Mohammadakbari Rostamabadi; Carlo La Vecchia; Ali Esmaeili-Nadimi
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

2.  Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice.

Authors:  Xiaoyu Hou; An Song; Yunpeng Guan; Peipei Tian; Luping Ren; Yong Tang; Chao Wang; Ling Gao; Guangyao Song; Xiaoping Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-18       Impact factor: 5.555

3.  Prevalence and Pattern of Dyslipidemia and Its Associated Factors Among Patients with Type 2 Diabetes Mellitus in Jordan: A Cross-Sectional Study.

Authors:  Thekraiat M Al Quran; Ziad A Bataineh; Abdel-Hameed Al-Mistarehi; Anas M Zein Alaabdin; Hadeel Allan; Anood Al Qura'an; Shatha M Weshah; Anfal A Alanazi; Yousef S Khader
Journal:  Int J Gen Med       Date:  2022-10-04

4.  Cross-sectional study of passive opiate smoking in relation to stroke and some of stroke attributable risk factors in women.

Authors:  Nazanin Jalali; Parvin Khalili; Saeed Bahrampour; Mohammad Mahmoudabadi; Ali Esmaeili Nadimi; Zahra Jalali
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.